Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the DreaMed Advisor Pro System in Subjects With Type 1 Diabetes Treated With Multiple Daily Injections of Insulin

NCT04043260 is registered in ClinicalTrials.gov with DreaMed Diabetes as lead sponsor.

NCT NCT04043260
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04043260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the DreaMed Advisor Pro System in Subjects With Type 1 Diabetes Treated With Multiple Daily Injections of Insulin
Lead sponsor
DreaMed Diabetes
Phase
Not applicable
Overall status
Completed
Start date
November 27, 2019
Completion date
April 30, 2021
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 1, insulin-dependent diabetes mellitus